Literature DB >> 33561338

Is there an association between labor induction and attention-deficit/hyperactivity disorder among children?

Ensiyeh Jenabi1, Mahdieh Seyedi1, Saeid Bashirian2, Bita Fereidooni3.   

Abstract

There is evidence of destructive effects of oxytocin use during labor on neurodevelopment. This meta-analysis pooled all observational studies to determine the association between labor induction and the risk of attention-deficit/hyperactivity disorder (ADHD) among children. All observational studies (case-control and cohort) were reviewed until September 2020 after searches of the PubMed, Scopus, and Web of Science databases, the gray literature, and conference proceedings. The pooled odds ratios (OR), relative ratios (RR), and 95% confidence intervals (CI (were calculated as random effect estimates of association among studies. All observational studies were reviewed, including four cohort studies including 2,885,743 participants and three case-control studies including 51,135 participants (10,961 with ADHD and 40,174 in control groups) with a sample size of 2,936,878 participants. The pooled estimates of OR and RR did not indicate a significant association between labor induction and ADHD among children (OR, 1.13; 95% CI, 0.90-1.35) and (RR, 1.10; 95% CI, 0.96-1.24). The findings showed that labor induction is not associated with an increased risk of ADHD among children. However, more studies are needed to investigate the relationship between labor induction and ADHD.

Entities:  

Keywords:  ADHD; Attention-deficit/hyperactivity disorder; Labor induction; Meta-analysis

Year:  2021        PMID: 33561338     DOI: 10.3345/cep.2020.01557

Source DB:  PubMed          Journal:  Clin Exp Pediatr        ISSN: 2713-4148


  1 in total

1.  A nationwide cohort study on the risk of ADHD in children with amblyopia mediated by fine motor skill impairment in East Asia.

Authors:  Myungjin Kim; Seungwon Lee; Jung Eun Lee; Ju Hee Kim; Eun Kyo Ha; Manyong Han; Helen Lew
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.